Medical Technologies Innovation Facility (MTIF) hosted a tour of its facilities featuring VALIRX PLC CEO Mark Eccleston, Director of Research Michelle B., head of Sci Ops for Inaphaea BioLabs, COO for VALIRX PLC Animal Health, and Lead Scientist Amelia Hatfield at Inaphaea BioLabs.

The Medical Technologies Innovation Facility is at the heart of a unique partnership that supports the development of innovative medical technologies from bench to bedside. We are able to support the development of a wide range of medical technologies through our capabilities in: - Biomaterials, - Cell, Molecule, Material Interactions, - Smart Textiles, - Surgical Robotics, - Product Design and Prototyping, - Hardware and Software Interfacing, - Human Factors, - Microbiology, - Imaging Working with partners from across the East Midlands we are able to take concepts through prototyping and in vitro testing to full scale clinical trials in our partner hospitals. All our work is designed to enable you to meet the requirements of the Medical Devices Regulation (MDR 2017/745) and In Vitro Diagnostics Regulation (IVDR 2017/746).